Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Mahesh Karande
|
| gptkbp:developedBy |
OMEGA platform
epigenetic medicines |
| gptkbp:focusesOn |
epigenomic programming
|
| gptkbp:foundedYear |
2017
|
| gptkbp:founder |
gptkb:Flagship_Pioneering
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Omega Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
OTX-2002
|
| gptkbp:parentCompany |
gptkb:Flagship_Pioneering
|
| gptkbp:pipeline |
immunology
oncology liver diseases |
| gptkbp:stockSymbol |
OMGA
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:website |
https://omegatherapeutics.com/
|
| gptkbp:bfsParent |
gptkb:Fine_Structure_Ventures
|
| gptkbp:bfsLayer |
7
|